Amgen Inc.: revenue
| Value | {"amount": 23362000000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"} |
|---|---|
| Period | 2019-01-01 – 2019-12-31 |
| Status | current |
| Entity | Amgen Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T07:29:18.426456+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2313659f-4b6f-4ccc-9c14-c60018d9b6ab
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000318154-22-000010Retrieved: 2026-08-19T07:29:18.426456+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000318154/revenue/2019-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2313659f-4b6f-4ccc-9c14-c60018d9b6ab
History
- supersedes {"amount": 23362000000, "concept": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "currency": "USD"} (evidence 0000318154-20-000017)